S&P Futures
6,007.25 +3.50 (+0.06%) Dow Futures
43,899.00 -11.00 (-0.03%) Nasdaq Futures
21,231.75 +7.00 (+0.03%) Russell 2000 Futures
2,399.10 +3.40 (+0.14%) Crude Oil
71.28 -1.08 (-1.49%) Gold
2,695.70 -10.10 (-0.37%)
NRx Pharmaceuticals, Inc. (NRXPW)
| Previous Close | 0.0631 |
| Open | 0.0752 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0752 - 0.0761 |
| 52 Week Range | 0.0752 - 0.0761 |
| Volume | |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (5Y Monthly) | 1.27 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -6.2470 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PR NewswireNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter and Year to Date 2024 Financial Results on November 14, 2024
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that it will release its third quarter and year to date 2024 financial results after the market closes on Thursday, November 14, 2024, via press release, which will be available on the Company's website at https://ir.nrxpharma.com/. The Company will host a conference call to discuss the financial results as well as provide a corporate update at 4:30pm ET th
GlobeNewswireNRx Pharmaceuticals added to Emerging Growth Conference 76 on October 31 and Update to Schedule
MIAMI, Oct. 31, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces NRx Pharmaceuticals (NASDAQ: NRXP) will appear on the Emerging Growth Conference today in response to multiple requests and investor demand. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Jonathan Javitt, M
